• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Horizon Technology Finance Announces First Quarter 2023 Financial Results

    5/2/23 4:15:00 PM ET
    $HRZN
    $IMV
    Finance: Consumer Services
    Finance
    Pharmaceuticals and Biotechnology
    Health Care
    Get the next $HRZN alert in real time by email

    - First Quarter 2023 Net Investment Income per Share of $0.46; NAV per Share of $11.34 -

    - Debt Portfolio Yield of 16.3% -

    - Grew Portfolio Year over Year by 39% to $715 Million -

    - Horizon Platform Ends Quarter with Committed Backlog of $218 Million, Including $187 Million in HRZN Commitments -

    - Declares Regular Monthly Distributions Totaling $0.33 per Share -

    FARMINGTON, Conn., May 2, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN", "Horizon" or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the first quarter ended March 31, 2023.

    First Quarter 2023 Highlights

    • Net investment income ("NII") of $13.0 million, or $0.46 per share, compared to $5.7 million, or $0.26 per share for the prior-year period
    • Total investment portfolio of $715.3 million as of March 31, 2023
    • Net asset value of $321.7 million, or $11.34 per share, as of March 31, 2023
    • Annualized portfolio yield on debt investments of 16.3% for the quarter
    • HRZN funded eight loans totaling $40.2 million
    • HRZN's investment adviser, Horizon Technology Finance Management LLC ("HTFM"), originated $46.7 million through its lending platform ("Horizon Platform"), inclusive of the loans funded by Horizon
    • Raised total net proceeds of approximately $7.2 million with "at-the-market" ("ATM") offering program
    • Experienced liquidity events from five portfolio companies
    • Cash of $43.5 million and credit facility capacity of $133.3 million as of March 31, 2023
    • Held portfolio of warrant and equity positions in 99 companies as of March 31, 2023
    • Undistributed spillover income of $0.81 per share as of March 31, 2023
    • Subsequent to quarter end, declared distributions of $0.11 per share payable in July, August and September 2023
    • Horizon announced that HTFM, Horizon's investment adviser, had entered into a definitive agreement to be acquired by an affiliate of Monroe Capital LLC, a premier boutique middle market asset manager

    "In the face of an increasingly challenging macro environment, we were able to deliver NII of $0.46 per share for the quarter – once again exceeding our distributions – and a strong debt portfolio yield of over 16%, driven by the rising rate environment and our predictive pricing strategy," said Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer of Horizon. "We also selectively originated additional venture debt loans while maintaining a solid committed backlog of debt investments, many of which are subject to the achievement of certain milestones by our borrowers. Given our strong balance sheet and disciplined underwriting, we believe we can further prudently grow HRZN's portfolio of debt investments."

    "While credit was impacted due to the macroeconomic uncertainty and volatility in the banking sector, we remain laser-focused on working with our portfolio companies to assist them in a difficult capital raising environment," continued Mr. Pomeroy. "As we look ahead, we believe the Horizon Platform and HRZN continue to be well positioned to deliver additional value to its shareholders."

    First Quarter 2023 Operating Results

    Total investment income for the quarter ended March 31, 2023 grew 97.4% to $28.0 million, compared to $14.2 million for the quarter ended March 31, 2022, primarily due to growth in interest income on investments resulting from an increase in the average size of the debt investment portfolio and an increase in the base rate for most of the Company's variable rate debt investments.

    The Company's dollar-weighted annualized yield on average debt investments for the quarter ended March 31, 2023 and 2022 was 16.3% and 12.4%, respectively.  The Company calculates the dollar-weighted annualized yield on average debt investments for any period measured as (1) total investment income (excluding dividend income) during the period divided by (2) the average of the fair value of debt investments outstanding on (a) the last day of the calendar month immediately preceding the first day of the period and (b) the last day of each calendar month during the period. The dollar-weighted annualized yield on average debt investments is higher than what investors will realize because it does not reflect expenses or any sales load paid by investors.

    Total expenses for the quarter ended March 31, 2023 were $14.8 million, compared to $8.4 million for the quarter ended March 31, 2022.  The increase was primarily due to a $3.7 million increase in interest expense, a $1.0 million increase in the base management fee and a $1.6 million increase in the performance-based incentive fee.

    Net investment income for the quarter ended March 31, 2023 was $13.0 million, or $0.46 per share, compared to $5.7 million, or $0.26 per share, for the quarter ended March 31, 2022.

    For the quarter ended March 31, 2023, net realized loss on investments was $0.2 million, or $0.01 per share, compared to a slight net realized gain on investments, for the quarter ended March 31, 2022.

    For the quarter ended March 31, 2023, net unrealized depreciation on investments was $7.5 million, or $0.26 per share, compared to $2.2 million, or $0.10 per share, for the prior-year period.

    Portfolio Summary and Investment Activity

    As of March 31, 2023, the Company's debt portfolio consisted of 57 secured loans with an aggregate fair value of $684.6 million. In addition, the Company's total warrant, equity and other investments in 101 portfolio companies had an aggregate fair value of $30.8 million.  Total portfolio investment activity for the three months ended March 31, 2023 and 2022 was as follows:

    ($ in thousands)

    For the Three Months Ended  

    March 31,



    2023

    2022

    Beginning portfolio

    $              720,026

    $              458,075







    New debt investments

    47,008

    94,485







    Principal payments received on investments

    (6,815)

    (2,095)







    Payment-in-kind interest on investments

    1,204

    —







    Early pay-offs and principal paydowns

    (32,941)

    (12,050)







    Accretion of debt investment fees

    1,448

    1,006







    New debt investment fees

    (300)

    (925)







    Proceeds from sale of investments

    (6,520)

    (21,280)







    Net realized (loss) gain on investments

    (168)

    30







    Net unrealized depreciation on investments

    (7,537)

    (2,237)







    Other

    (93)

    —







    Ending portfolio

    $              715,312

    $              515,009

    Portfolio Asset Quality

    The following table shows the classification of Horizon's loan portfolio at fair value by internal credit rating as of March 31, 2023 and December 31, 2022:

    ($ in thousands)

    March 31, 2023



    December 31, 2022





    Number of

    Investments

    Debt

    Investments at

    Fair Value

    Percentage

    of Debt

    Investments



    Number of

    Investments

    Debt

    Investments at

    Fair Value

    Percentage

    of Debt

    Investments



    Credit

    Rating

















    4

    9

    $      108,482

    15.8 %



    8

    $       93,832

    13.7 %



    3

    38

    483,615

    70.6 %



    47

    557,554

    81.2 %



    2

    7

    87,206

    12.7 %



    2

    26,822

    3.9 %



    1

    3

    5,251

    0.9 %



    3

    8,250

    1.2 %



    Total

    57

    $     684,554

    100.0 %



    60

    $     686,458

    100.0 %



    As of March 31, 2023 and December 31, 2022, Horizon's loan portfolio had a weighted average credit rating of 3.0 and 3.1, respectively, with 4 being the highest credit quality rating and 3 being the rating for a standard level of risk.  A rating of 2 represents an increased level of risk and, while no loss is currently anticipated for a 2-rated loan, there is potential for future loss of principal.  A rating of 1 represents deteriorating credit quality and high degree of risk of loss of principal.

    As of March 31, 2023, there were three debt investments with an internal credit rating of 1, with an aggregate cost of $20.3 million and an aggregate fair value of $5.3 million.  As of December 31, 2022, there were three debt investments with an internal credit rating of 1, with an aggregate cost of $20.9 million and an aggregate fair value of $8.3 million.

    Liquidity and Capital Resources

    As of March 31, 2023, the Company had $112.3 million in available liquidity, consisting of $43.5 million in cash and money market funds, and $68.8 million in funds available under existing credit facility commitments.

    As of March 31, 2023, there was $15.0 million in outstanding principal balance under the $125.0 million revolving credit facility ("Key Facility").  The Key Facility allows for an increase in the total loan commitment up to an aggregate commitment of $150.0 million. There can be no assurance that any additional lenders will make any commitments under the Key Facility.

    Additionally, as of March 31, 2023, there was $176.8 million in outstanding principal balance under the $200 million senior secured debt facility with a large U.S.-based insurance company at an interest rate of 5.57%. 

    Horizon Funding Trust 2019-1, a wholly-owned subsidiary of HRZN, previously issued $100.0 million of Asset-Backed Notes (the "Notes") rated A+(sf) by Morningstar Credit Ratings, LLC.  The Notes bear interest at a fixed interest rate of 4.21% per annum.   The reinvestment period of the Notes ended July 15, 2021 and the stated maturity is September 15, 2027. As of March 31, 2023, the Notes had an outstanding principal balance of $37.8 million.

    Horizon Funding Trust 2022-1, a wholly-owned subsidiary of Horizon, previously issued $100.0 million of Asset-Backed Notes (the "2022 Notes") rated A by a ratings agency.  The 2022 Notes bear interest at a fixed interest rate of 7.56% per annum.   The reinvestment period of the 2022 Notes ends November 15, 2024 and the stated maturity is November 15, 2030. As of March 31, 2023, the 2022 Notes had an outstanding principal balance of $100.0 million.

    During the three months ended March 31, 2023, the Company sold 605,848 shares of common stock under its ATM offering program with Goldman Sachs & Co. LLC and B. Riley FBR, Inc.  For the same period, the Company received total accumulated net proceeds of approximately $7.2 million, including $0.2 million of offering expenses, from these sales.

    As of March 31, 2023, the Company's net debt to equity leverage ratio was 124%, above the Company's 120% targeted leverage.  The asset coverage ratio for borrowed amounts was 172%.

    Liquidity Events

    During the quarter ended March 31, 2023, Horizon experienced liquidity events from five portfolio companies. Liquidity events for Horizon may consist of the sale of warrants or equity in portfolio companies, loan prepayments or partial paydowns, sale of owned assets or receipt of success fees.

    In February, Canary Medical Inc. prepaid its outstanding principal balance of $7.5 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company.

    In February, Embody, Inc. paid its outstanding principal balance of $2.5 million on its venture loan, plus interest and end-of-term payment.

    In February, HRZN received a partial paydown of $3.2 million on its venture loan to Unagi Inc.

    In March, Alula Holdings, Inc. prepaid its outstanding principal balance of $13.9 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company.

    In March, F-Star Therapeutics, Inc. prepaid its outstanding principal balance of $5.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee.

    Net Asset Value

    At March 31, 2023, the Company's net assets were $321.7 million, or $11.34 per share, compared to $280.0 million, or $11.68 per share, as of March 31, 2022, and $318.4 million, or $11.47 per share, as of December 31, 2022. 

    For the quarter ended March 31, 2023, net increase in net assets resulting from operations was $5.3 million, or $0.19 per share, compared to a net increase in net assets resulting from operations of $3.5 million, or $0.16 per share, for the quarter ended March 31, 2022.

    Stock Repurchase Program

    On April 28, 2023, the Company's board of directors extended the Company's previously authorized stock repurchase program until the earlier of June 30, 2024 or the repurchase of $5.0 million of the Company's common stock. During the quarter ended March 31, 2023, the Company did not repurchase any shares of its common stock. From the inception of the stock repurchase program through March 31, 2023, the Company has repurchased 167,465 shares of its common stock at an average price of $11.22 on the open market at a total cost of $1.9 million.

    Recent Developments

    In April 2023, the Company sold 272,303 shares of common stock under the ATM offering program. For the same period, the Company received total accumulated net proceeds of approximately $3.1 million, including $0.1 million of offering expenses, from these sales.

    IMV Inc. ("IMV") (NASDAQ:IMV, TSX:IMV), announced on May 1, 2023 that the Nova Scotia Supreme Court has issued an initial order (the "Initial Order") granting IMV and its subsidiaries protection under the Companies' Creditors Arrangement Act (R.S.C., 1985, c. C-36) and IMV will seek the recognition of the Initial Order in the United States by filing a petition commencing proceedings under the Chapter 15 of the United States Bankruptcy Code.

    Monthly Distributions Declared in Second Quarter 2023

    On April 28, 2023, the Company's board of directors declared monthly distributions of $0.11 per share payable in each of July, August and September 2023.  The following table shows these monthly distributions, which total $0.33 per share:

    Monthly Distributions

    Ex-Dividend Date

    Record Date

    Payment Date

    Amount per Share

    June 15, 2023

    June 16, 2023

    July 14, 2023

    $0.11

    July 17, 2023

    July 18, 2023

    August 15, 2023

    $0.11

    August 16, 2023

    August 17, 2023

    September 15, 2023

    $0.11





    Total:

    $0.33

    After paying distributions of $0.33 per share and earning net investment income of $0.46 per share for the quarter, the Company's undistributed spillover income as of March 31, 2023 was $0.81 per share. Spillover income includes any ordinary income and net capital gains from the preceding tax years that were not distributed during such tax years.

    When declaring distributions, the Horizon board of directors reviews estimates of taxable income available for distribution, which may differ from consolidated net income under generally accepted accounting principles due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given year for distribution in the following year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.

    Conference Call

    The Company will host a conference call on Wednesday, May 3, 2023, at 9:00 a.m. ET to discuss its latest corporate developments and financial results. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (international). The access code for all callers is 13737098.  The Company recommends joining the call at least 10 minutes in advance.  In addition, a live webcast will be available on the Company's website at www.horizontechfinance.com. 

    A webcast replay will be available on the Company's website for 30 days following the call.

    About Horizon Technology Finance

    Horizon Technology Finance Corporation (NASDAQ:HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located in Austin, Texas, Chicago, Illinois, Reston, Virginia and Portland, Maine. To learn more, please visit horizontechfinance.com. 

    Forward-Looking Statements

    Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in HRZN's filings with the Securities and Exchange Commission. HRZN undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

    Contacts:

    Investor Relations:

    ICR

    Garrett Edson

    [email protected]

    (860) 284-6450

    Media Relations:

    ICR

    Chris Gillick

    [email protected]

    (646) 677-1819

     

    Horizon Technology Finance Corporation and Subsidiaries



    Consolidated Statements of Assets and Liabilities



    (Dollars in thousands, except share and per share data)









    March 31,

    December 31,





    2023



    2022





    (unaudited)







    Assets









    Non-affiliate investments at fair value (cost of $724,162 and $721,248, respectively)

    $       714,466



    $     720,026



    Non-controlled affiliate investments at fair value (cost of $0 and $0, respectively)

    846



    —



    Total investments at fair value (cost of $724,162 and $721,248, respectively)

    715,312



    720,026



    Cash

    19,844



    20,612



    Investments in money market funds

    23,698



    7,066



    Restricted investments in money market funds

    2,987



    2,788



    Interest receivable

    13,843



    13,573



    Other assets

    2,554



    2,761



    Total assets

    $       778,238



    $     766,826













    Liabilities









    Borrowings

    $       439,645



    $     434,078



    Distributions payable

    9,365



    9,159



    Base management fee payable

    1,059



    1,065



    Incentive fee payable

    2,978



    1,392



    Other accrued expenses

    3,508



    2,684



    Total liabilities

    456,555



    448,378













    Commitments and contingencies



















    Net assets









    Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero

         shares issued and outstanding as of March 31, 2023 and December 31, 2022

    —



    —



    Common stock, par value $0.001 per share, 100,000,000 shares authorized,

         28,544,822 and 27,920,838 shares issued and 28,377,357 and 27,753,373 shares outstanding as of

         March 31, 2023 and December 31, 2022, respectively

    30



    29



    Paid-in capital in excess of par

    393,312



    385,921



    Distributable earnings

    (71,659)



    (67,502)



    Total net assets

    321,683



    318,448



    Total liabilities and net assets

    $       778,238



    $    766,826



    Net asset value per common share

    $           11.34



    $        11.47



     

    Horizon Technology Finance Corporation and Subsidiaries

    Consolidated Statements of Operations (Unaudited)

    (Dollars in thousands, except share and per share data)





    For the Three Months Ended





    March 31,





    2023



    2022



    Investment income









    Interest income on investments









    Interest income on non-affiliate investments

    $          27,399



    $          13,853



    Fee income on non-affiliate investments

    638



    351



    Total investment income

    28,037



    14,204



    Expenses









    Interest expense

    7,120



    3,424



    Base management fee

    3,201



    2,244



    Performance based incentive fee

    2,978



    1,424



    Administrative fee

    440



    362



    Professional fees

    658



    577



    General and administrative

    445



    344



    Total expenses

    14,842



    8,375



    Net investment income before excise tax

    13,195



    5,829



    Provision for excise tax

    184



    100



    Net investment income

    13,011



    5,729



    Net realized and unrealized loss









    Net realized (loss) gain on non-affiliate investments

    (168)



    30



    Net realized (loss) gain on investments

    (168)



    30



    Net unrealized depreciation on non-affiliate investments

    (8,383)



    (2,287)



    Net unrealized appreciation on non-controlled affiliate investments

    846



    —



    Net unrealized appreciation on controlled affiliate investments

    —



    50



    Net unrealized depreciation on investments

    (7,537)



    (2,237)



    Net realized and unrealized loss

    (7,705)



    (2,207)



    Net increase in net assets resulting from operations

    $            5,306



    $            3,522



    Net investment income per common share

    $              0.46



    $              0.26



    Net increase in net assets per common share

    $              0.19



    $              0.16



    Distributions declared per share

    $              0.33



    $              0.30



    Weighted average shares outstanding

    28,227,100



    21,904,160



     

    Cision View original content:https://www.prnewswire.com/news-releases/horizon-technology-finance-announces-first-quarter-2023-financial-results-301813737.html

    SOURCE Horizon Technology Finance Corporation

    Get the next $HRZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HRZN
    $IMV

    CompanyDatePrice TargetRatingAnalyst
    Horizon Technology Finance Corporation
    $HRZN
    5/13/2025$7.00Neutral
    B. Riley Securities
    Horizon Technology Finance Corporation
    $HRZN
    4/30/2025$6.50Neutral → Sell
    Compass Point
    Horizon Technology Finance Corporation
    $HRZN
    12/17/2024$8.25Sell → Neutral
    Compass Point
    Horizon Technology Finance Corporation
    $HRZN
    2/28/2024Buy → Neutral
    Ladenburg Thalmann
    Horizon Technology Finance Corporation
    $HRZN
    1/8/2024$11.00Neutral → Sell
    B. Riley Securities
    Horizon Technology Finance Corporation
    $HRZN
    10/17/2023$10.00Neutral → Sell
    Compass Point
    Horizon Technology Finance Corporation
    $HRZN
    9/27/2023$11.00 → $10.50Sell → Neutral
    Compass Point
    Horizon Technology Finance Corporation
    $HRZN
    8/4/2023$11.00Neutral → Sell
    Compass Point
    More analyst ratings

    $HRZN
    $IMV
    SEC Filings

    View All

    Horizon Technology Finance Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Horizon Technology Finance Corp (0001487428) (Filer)

    2/11/26 4:53:02 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    SEC Form 40-33 filed by Horizon Technology Finance Corporation

    40-33 - Horizon Technology Finance Corp (0001487428) (Filer)

    2/6/26 5:13:08 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    SEC Form 25-NSE filed by Horizon Technology Finance Corporation

    25-NSE - Horizon Technology Finance Corp (0001487428) (Subject)

    1/29/26 3:17:43 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    $IMV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Horizon Technology Finance to Announce Fourth Quarter 2025 Financial Results

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, announced today that it plans to release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 4, 2026, at 9:00 a.m. ET. The conference call will feature remarks by Mike Balkin, Chief Executive Officer, Paul Seitz, Senior Vice President and Chief Investment Officer, and Dan Trolio, Executive Vice President and Chief Financial Officer. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (interna

    2/17/26 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance and Monroe Capital Support OSSIO with a $50 Million Credit Facility for Continued Growth

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), together with Monroe Capital LLC ("Monroe"), today announced the closing of an initial $40 million senior credit facility for Ossio Inc. ("OSSIO"), with an additional $10 million available to support future growth. Founded in 2014, OSSIO is an orthopedics company committed to transforming the surgical experience for patients, physicians, providers and payors. The company's vision is to provide the first credible replacement for metal implants in the multibillion-dollar global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO conducts product development and manufacturing in Caesarea,

    2/11/26 6:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, today announced it has provided a $50 million venture loan facility to Pelthos Therapeutics Inc. (NYSE:PTHS) ("Pelthos"), with an initial funding of $30 million, and up to $20 million to support future growth. Pelthos is a publicly traded biopharmaceutical company that is licensed to commercialize ZELSUVMI™ (berdazimer) topical gel, an FDA-approved treatment of molluscum contagiosum, a common skin infection characterized by small bumps or lesions. ZELSUVMI delivers nitric oxide directly to the affected skin or tissue via the Nitricil platform, which enables the gel to slowly a

    1/15/26 4:10:00 PM ET
    $HRZN
    $PTHS
    Finance: Consumer Services
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $HRZN
    $IMV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Horizon Technology Finance with a new price target

    B. Riley Securities resumed coverage of Horizon Technology Finance with a rating of Neutral and set a new price target of $7.00

    5/13/25 10:04:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance downgraded by Compass Point with a new price target

    Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $6.50

    4/30/25 8:07:52 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance upgraded by Compass Point with a new price target

    Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25

    12/17/24 8:05:36 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    $IMV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Balkin Michael bought $170,600 worth of shares (20,000 units at $8.53) (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/17/24 1:23:10 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    President Michaud Gerald A. bought $74,519 worth of shares (8,000 units at $9.31), increasing direct ownership by 5% to 169,309 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/2/24 11:38:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Director Savage Joseph J bought $88,150 worth of shares (9,500 units at $9.28), increasing direct ownership by 19% to 59,500 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    11/14/24 4:23:08 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    $IMV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Seitz Paul G claimed ownership of 600 shares (SEC Form 3)

    3 - Horizon Technology Finance Corp (0001487428) (Issuer)

    6/26/25 2:54:53 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Director Balkin Michael bought $170,600 worth of shares (20,000 units at $8.53) (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/17/24 1:23:10 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    President Michaud Gerald A. bought $74,519 worth of shares (8,000 units at $9.31), increasing direct ownership by 5% to 169,309 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/2/24 11:38:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    $IMV
    Leadership Updates

    Live Leadership Updates

    View All

    Horizon Technology Finance Appoints Paul Seitz as Chief Investment Officer

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or "HRZN") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity backed and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it has appointed Paul Seitz as its new Chief Investment Officer. Concurrently, Daniel Devorsetz has stepped down as Chief Operating Officer and Chief Investment Officer, but will remain involved with the Company through September 2025. "We are thrilled to welcome Paul as our new Chi

    6/9/25 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Vesta Healthcare Raises $65 Million in Financing to Propel Growth

    Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr

    9/4/24 8:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    IMV Inc. Announces Strategic Reorganization

    Reorganization enhances organizational focus on strategic priorities Clinical update on DLBCL patients in Phase 2B VITALIZE trial to be provided in September Appointment of Dr. Saman Maleki to Board of Directors Brittany Davison promoted to Chief Accounting Officer IMV Inc. (NASDAQ:IMV, TSX:IMV) ("IMV" or the "Company"), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX™ platform to treat solid and hematologic cancers, today announced a strategic reorganization together with the appointment of Dr. Saman Maleki to the Company's Board of Directors and promotion of Brittany Davison to Chief Accounting Officer. "We have m

    9/15/22 7:45:00 AM ET
    $IMV
    Pharmaceuticals and Biotechnology
    Health Care

    $HRZN
    $IMV
    Financials

    Live finance-specific insights

    View All

    Horizon Technology Finance to Announce Fourth Quarter 2025 Financial Results

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, announced today that it plans to release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 4, 2026, at 9:00 a.m. ET. The conference call will feature remarks by Mike Balkin, Chief Executive Officer, Paul Seitz, Senior Vice President and Chief Investment Officer, and Dan Trolio, Executive Vice President and Chief Financial Officer. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (interna

    2/17/26 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance Announces Third Quarter 2025 Financial Results

    - Third Quarter 2025 Net Investment Income per Share of $0.32; NAV per Share of $7.12 - - Debt Portfolio Yield of 18.6% - - HRZN Ends Quarter with Committed Backlog of $119 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through March 2026 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial

    10/28/25 4:15:00 PM ET
    $HRZN
    $MRCC
    Finance: Consumer Services
    Finance
    Investment Managers

    Horizon Technology Finance to Announce Third Quarter 2025 Financial Results

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the third quarter ended September 30, 2025 on Tuesday, October 28, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, October 29, 2025, at 9:00 a.m. ET. The conference call will

    10/14/25 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    $IMV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by IMV Inc.

    SC 13G - IMV Inc. (0001734768) (Subject)

    2/14/23 12:57:14 PM ET
    $IMV
    Pharmaceuticals and Biotechnology
    Health Care

    SEC Form SC 13G/A filed by IMV Inc. (Amendment)

    SC 13G/A - IMV Inc. (0001734768) (Subject)

    2/3/23 12:06:43 PM ET
    $IMV
    Pharmaceuticals and Biotechnology
    Health Care

    SEC Form SC 13G/A filed by IMV Inc. (Amendment)

    SC 13G/A - IMV Inc. (0001734768) (Subject)

    7/21/21 2:03:29 PM ET
    $IMV
    Pharmaceuticals and Biotechnology
    Health Care